Christmas Patrick J. 4
4 · REGENXBIO Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Christmas Patrick J.
Chief Strategy & Legal Officer
Transactions
- Tax Payment
Common Stock
2022-01-01$32.70/sh−1,332$43,556→ 15,040 total - Award
Stock Option (Right to Buy)
2022-01-03+37,400→ 37,400 totalExercise: $34.31Exp: 2032-01-03→ Common Stock (37,400 underlying) - Award
Common Stock
2022-01-03+7,900→ 22,940 total
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer.
- [F2]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer.